Frankfurt - Delayed Quote EUR

Mesa Laboratories, Inc. (MLI.F)

Compare
96.50
-8.50
(-8.10%)
As of 8:00:34 AM GMT+2. Market Open.
Loading Chart for MLI.F
  • Previous Close 105.00
  • Open 96.50
  • Bid 89.00 x --
  • Ask 93.50 x --
  • Day's Range 96.50 - 96.50
  • 52 Week Range 78.00 - 148.00
  • Volume 160
  • Avg. Volume 4
  • Market Cap (intraday) 524.343M
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) --
  • EPS (TTM) -42.47
  • Earnings Date May 29, 2025 - Jun 2, 2025
  • Forward Dividend & Yield 0.59 (0.56%)
  • Ex-Dividend Date Feb 28, 2025
  • 1y Target Est --

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

www.mesalabs.com

736

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MLI.F

View More

Performance Overview: MLI.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MLI.F
23.32%
S&P 500 (^GSPC)
11.13%

1-Year Return

MLI.F
6.62%
S&P 500 (^GSPC)
1.55%

3-Year Return

MLI.F
57.39%
S&P 500 (^GSPC)
14.06%

5-Year Return

MLI.F
48.67%
S&P 500 (^GSPC)
110.03%

Compare To: MLI.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLI.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    537.98M

  • Enterprise Value

    703.64M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.62

  • Price/Book (mrq)

    4.01

  • Enterprise Value/Revenue

    3.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -104.92%

  • Return on Assets (ttm)

    2.18%

  • Return on Equity (ttm)

    -89.38%

  • Revenue (ttm)

    237.75M

  • Net Income Avi to Common (ttm)

    -249.44M

  • Diluted EPS (ttm)

    -42.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.29M

  • Total Debt/Equity (mrq)

    136.34%

  • Levered Free Cash Flow (ttm)

    57.76M

Research Analysis: MLI.F

View More

Company Insights: MLI.F

Research Reports: MLI.F

View More

People Also Watch